Choroidal vascularity index in thyroid-associated ophthalmopathy



      To investigate the choroidal vascularity index (CVI) in patients with thyroid-associated ophthalmopathy (TAO) and its relationship with clinical features and clinical activity score


      Right eyes of 53 patients with TAO and 53 healthy subjects were scanned for subfoveal choroidal thickness (SFCT), CVI, choroid-stromal area (C-SA), choroid-luminal area (C-LA), choroidal stromal index (CSI), choroid-stromal-to-luminal-area ratio, and CVI and CSI within the central 1500 µm of the macula (CVI1500 and CSI1500) by enhanced-depth imaging optical coherence tomography. The results of the TAO group and the healthy controls were compared.


      The SFCT was significantly greater in the TAO group than in the control group (p = 0.02). The values of C-LA, C-SA, and total choroidal area (TCA) in the TAO group were significantly higher than those in the control group (p = 0.01, p = 0.04, and p = 0.01, respectively). The increases in SFCT, C-LA, C-SA, and TCA were 12.1%, 12.2%, 16.2%, and 13.6%, respectively. There was no statistically significant difference between the groups for CVI, CSI, CVI1500, CSI1500, and choroid-stromal-to-luminal-area ratio (p > 0.05). CVI1500 and CSI1500 have displayed a statistically significant correlation with exophthalmometry and clinical activity score (p < 0.05).


      The alterations in stromal and vascular structures are proportionally similar in TAO; thus CVI may not be affected significantly. However, CVI1500 and CSI1500 may be associated with disease activity. The choroidal thickening in TAO may be the result not only of vascular mechanisms but also by an increase in stromal contents.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Canadian Journal of Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Yamada M
        • Li AW
        • Wall JR.
        Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management.
        Crit Rev Clin Lab Sci. 2000; 37: 523-549
        • Nickla DL
        • Wallman J.
        The multifunctional choroid.
        Prog Retin Eye Res. 2010; 29: 144-168
        • Caliskan S
        • Acar M
        • Gurdal C.
        Choroidal thickness in patients with Graves’ ophthalmopathy.
        Curr Eye Res. 2017; 42: 484-490
        • Cagiltay E
        • Akay F
        • Demir O
        • et al.
        The increment of choroidal thickness in euthyroid Graves’ ophthalmopathy: is it an early sign of venous congestion?.
        J Ophthalmol. 2018; 2018 (eCollection 2018)5891531
        • Yu N
        • Zhang Y
        • Kang L
        • et al.
        Analysis of choroidal thickness in patients with Graves’ ophthalmopathy using spectral-domain optical coherence tomography.
        J Ophthalmol. 2018; 20183529395
        • Gul A
        • Basural E
        • Ozturk HE.
        Comparison of choroidal thickness in patients with active and stable thyroid eye disease.
        Arq Bras Oftalmol. 2019; 82: 124-128
        • Del Noce C
        • Vagge A
        • Nicolo M
        • et al.
        Evaluation of choroidal thickness and choroidal vascular blood flow in patients with thyroid-associated orbitopathy (TAO) using SD-OCT and angio-OCT.
        Graefes Arch Clin Exp Ophthalmol. 2020; 258: 1103-1107
        • Ozturk Karabulut G
        • Fazil K
        • Ozturker C
        • et al.
        Do ocular pulse amplitude and choroidal thickness change in patients with thyroid eye disease?.
        Orbit. 2019; 38: 347-352
        • Lai FHP
        • Iao TWU
        • Ng DSC
        • et al.
        Choroidal thickness in thyroid-associated orbitopathy.
        Clin Exp Ophthalmol. 2019; 47: 918-924
        • Ozkan B
        • Kocer CA
        • Altintas O
        • et al.
        Choroidal changes observed with enhanced depth imaging optical coherence tomography in patients with mild Graves’ orbitopathy.
        Eye (Lond). 2016; 30: 917-924
        • Konuk O
        • Onaran Z
        • Ozhan Oktar S
        • et al.
        Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves’ orbitopathy: relation with the clinical features.
        Graefes Arch Clin Exp Ophthalmol. 2009; 247: 1555-1559
        • Agrawal R
        • Gupta P
        • Tan KA
        • et al.
        Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study.
        Sci Rep. 2016; 6: 21090
        • Agrawal R
        • Ding J
        • Sen P
        • et al.
        Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index.
        Prog Retin Eye Res. 2020; 77 (Epub 2020 Jan 10)100829
        • Temel E
        • Kocamis O
        • Asikgarip N
        • et al.
        Evaluation of choroidal thickness and choroidal vascularity index during pregnancy [e-pub ahead of print].
        Can J Ophthalmol. 2021; (S0008-4182(20)30836-X. Accessed 6 Jan 2021)
        • Steiner M
        • Esteban-Ortega MDM
        • Munoz-Fernandez S.
        Choroidal and retinal thickness in systemic autoimmune and inflammatory diseases: a review.
        Surv Ophthalmol. 2019; 64: 757-769
        • Onaran Z
        • Konuk O
        • Oktar SO
        • et al.
        Intraocular pressure lowering effect of orbital decompression is related to increased venous outflow in Graves’ orbitopathy.
        Curr Eye Res. 2014; 39: 666-672
        • Sonoda S
        • Sakamoto T
        • Yamashita T
        • et al.
        Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images.
        Am J Ophthalmol. 2015; 159 (e1): 1123-1131
        • Tornquist P
        • Alm A
        • Bill A.
        Permeability of ocular vessels and transport across the blood-retinal-barrier.
        Eye (Lond). 1990; 4: 303-309
        • Bill A
        • Tornquist P
        • Alm A.
        Permeability of the intraocular blood vessels.
        Trans Ophthalmol Soc UK. 1980; 100: 332-336
        • Kumar S
        • Iyer S
        • Bauer H
        • et al.
        A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in Graves’ orbital fibroblasts: inhibition by an IGF-I receptor blocking antibody.
        J Clin Endocrinol Metab. 2012; 97: 1681-1687
        • Erdurmus M
        • Bekdas M
        • Demircioglu F
        • et al.
        Retinal and choroidal thickness in children with familial Mediterranean fever.
        Ocul Immunol Inflamm. 2014; 22: 444-448
        • Duru N
        • Altinkaynak H
        • Erten S
        • et al.
        Thinning of choroidal thickness in patients with rheumatoid arthritis unrelated to disease activity.
        Ocul Immunol Inflamm. 2016; 24: 246-253
        • Agin A
        • Kadayifcilar S
        • Sonmez HE
        • et al.
        Evaluation of choroidal thickness, choroidal vascularity index and peripapillary retinal nerve fiber layer in patients with juvenile systemic lupus erythematosus.
        Lupus. 2019; 28: 44-50
        • Eckstein AK
        • Plicht M
        • Lax H
        • et al.
        Clinical results of anti-inflammatory therapy in Graves’ ophthalmopathy and association with thyroidal autoantibodies.
        Clin Endocrinol (Oxf). 2004; 61: 612-618